Board summary
Key figures
25,420
Registered population
58.8% aged 18–64
20.8%
Aged 65+
ICB 21.9% · England 17.9%
8.6%
Ethnic minority (non-White)
3.9% Asian · England 9.6%
0.0%
In IMD quintile 1
ICB 9.2% · England 21.0%
0
Core20 residents (est.)
Resident basis; registered basis 0 · see page 3
3,531
Hypertension register
+2.73% in 3 yrs · England +5.60%
247
SMI register
17.8% of Mid Sussex's
282
COPD register
Reviews +5.74% in 3 yrs
Forecast to 2030
3,861
Hypertension patients, 2030
+330 on today
65.0%
QRISK ≥20% on statins, 2030
+3.01pp over 3 yrs
5.3%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
Wide practice spread in telephone contact ease.
Easy phone contact is 49.4% at Dolphins Practice against 84.5% at Newtons Practice (England 56.9%), which may reflect unverified telephony or triage differences.
Psychosis alcohol and SMI physical checks trail.
Alcohol recording reaches 67.7% (England 81.8%) and SMI BP checks reach 75.5% (Mid Sussex 84.7%), which could reflect unverified recall gaps.
Heart failure reviews and BP control ahead.
Heart failure reviews rose +56.1% over 2023 to 2025 (England +8.7%), while hypertension BP control reaches 70.9% (England 70.3%).
Population, age and ethnicity
Older adults comprise 20.8% of registered patients alongside 20 catchment care homes
Haywards Heath Central PCN's 25,420 registered patients have an older profile: 20.8% (5,288 patients) are aged 65+, compared to 20.0% in Mid Sussex, 21.9% in NHS Sussex ICB, and 17.9% in England. Dolphins Practice has 23.1% aged 65+ across 10,390 patients, and Newtons Practice records 19.2% aged 65+ across 15,030 patients. Registered children aged 0-17 comprise 20.4% (Mid Sussex 20.9%, ICB 17.7%, England 19.6%). Resident Census ethnicity records 91.4% White and 3.9% Asian or Asian British. Population growth to 2030 is projected at 2.6% using an unverified projection methodology.
Age profile
65+: ICB 21.9%, England 17.9%
Ethnicity
Older people · falls rows are Mid Sussex local-authority (LA) data, not PCN
| Measure | Local | South East | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Mid Sussex LA) | 2,494 | 2,018 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 76.8% | 82.2% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 54.3% | 57.8% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Mid Sussex LA) | 1,184 | 981 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Mid Sussex LA) | 13.7 | 14.0 | 14.8 | 2022‑24 |
Deprivation and Core20
Average deprivation is decile 8.6, with 0.0% of patients residing in Core20 areas
Haywards Heath Central PCN has low relative deprivation, with an average IMD decile of 8.6 compared to 8.3 in Mid Sussex, 6.1 in NHS Sussex Integrated Care Board, and 5.5 in England. Across Dolphins Practice (decile 8.5) and Newtons Practice (decile 8.6), 0.0% of registered patients live in Core20 areas, matching Mid Sussex (0.0%) and below NHS Sussex Integrated Care Board (9.2%) and England (21.0%). Area-based Core20 targeting identifies 0 patients locally, meaning health inequality work must focus on clinical inclusion groups.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
247
SMI register
0.98% recorded prevalence
78
Learning disability register
0.31% recorded prevalence
20
Care homes, 912 beds
In the PCN catchment
7.9%
Provide unpaid care
Mid Sussex, Census 2021
The PCN records 247 severe mental illness patients (1.0%, England 1.0%) and 78 on the learning disability register (0.3%, Mid Sussex 0.4%, England 0.6%). Recorded dementia prevalence is 1.4% (357 patients); three-year prevalence fell 2.9% over 2023 to 2025 (Mid Sussex +2.3%, England +6.0%). The PCN catchment includes 20 care homes with 912 beds.
Severe mental illness: physical health checks
Severe mental illness physical checks trail benchmarks: blood pressure recording is 75.5% (Mid Sussex 84.7%, England 83.4%), BMI recording is 74.5% (Mid Sussex 84.8%, England 82.1%), and alcohol recording is 67.7% (England 81.8%).
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
3,531
Hypertension register
+2.73%
Register growth, 3 yrs
Mid Sussex +5.64% · England +5.60%
+3.64pp
BP control, under 80
≤140/90 · +6.07pp aged 80+
+330
More patients by 2030
Forecast 3,861 (14.84%)
Hypertension case-finding and control
Recorded hypertension prevalence is 14.1% (3,531 patients), below Mid Sussex (16.1%), NHS Sussex ICB (16.3%) and England (15.2%), with 3-year growth of +2.7% over 2023 to 2025 trailing England's +5.6%. Unadjusted benchmark scenarios indicate an upper bound of +340 to +554 patients against England and Mid Sussex, though crude rates do not establish under-detection. Blood pressure control reaches 70.9% of hypertension patients treated to target (England 70.3%), with 70.7% in patients aged under 80 and 80.8% in patients aged 80 and over.
Lipids and statins
Lipid-lowering therapy uptake consistently lags comparators: QRISK ≥ 20% reaches 58.5% (England 63.6%), CKD reaches 59.3% (England 70.3%), diabetes with CVD reaches 76.6% (England 84.4%), and diabetes without CVD reaches 67.9% (England 73.2%). Prescribing volume in patients aged 65+ is 5,181 items per 1,000 against England's 18,056.
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 27,397 | £2.50 | £2.42 | £1.86 | £68,492 |
| Cardiovascular (all), 2025 | 42,334 | £3.79 | £3.32 | £3.33 | £160,446 |
In 2026, the PCN prescribed 27,397 lipid-regulating items with an annual spend of £68,492 at £2.50 per item, matching Mid Sussex (£2.50) but higher than NHS Sussex Integrated Care Board (£2.42) and England (£1.86). Across 27,397 items, the PCN spends £17,534 more than at England's unit cost and £2,192 more than at the ICB's unit cost.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
+18.47%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
+3.00%
Asthma prevalence, PCN 3-yr % change
Recorded asthma prevalence is 6.7% (1,587 patients), compared to England (6.6%) and Mid Sussex (7.2%). Annual asthma reviews increased +18.5% over 2023 to 2025 to 66.0% (Mid Sussex 66.3%, England 65.7%), spanning 71.5% at Dolphins Practice to 61.3% at Newtons Practice, leaving about 540 patients unreviewed. COPD prevalence is 1.1% (282 patients) versus 1.4% in Mid Sussex and 1.9% in England, with annual reviews at 75.2% (Mid Sussex 78.4%, England 76.4%).
Cancer register and children's immunisation
Cancer register prevalence is 4.7% (1,173 patients), matching Mid Sussex (4.7%) and above England (3.8%). Childhood immunisations exceed benchmarks: 6-in-1 at 12 months reaches the 95.0% target (NHS Sussex ICB 92.9%, England 91.0%). MMR dose 1 at 24 months is 92.3%, trailing the 95.0% target by 2.7 pp, while age-5 MMR2 is 94.9% (3.4 pp below dose 1 at 98.3%). Scheduled recall could protect targets.
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
58.5%
Sussex ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~1,360
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Sussex ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Prostate | 56.6% | 53.2% | 19% | 1,668 |
| Breast | 86.1% | 85.4% | 23% | 1,400 |
| Bowel | 49.8% | 47.0% | 26% | 1,133 |
| Lung | 30.3% | 33.8% | 15% | 1,058 |
| Skin cancer | 95.3% | 87.8% | 17% | 698 |
Across NHS Sussex ICB, 58.5% of staged cancers (4,799 of 8,209 known-stage cases) were diagnosed at stage 1 or 2 in 2022 (England 55.3%), with a distance of -16.5 pp to the 75.0% national ambition by 2028; staging was recorded for 64.3% of registered cancers. In primary care, PCN cervical screening coverage in women aged 25 to 49 is 70.1%, above England (66.8%) but below Mid Sussex (73.2%), changing -1.6% over 2023 to 2025 (England -1.0%). Dolphins Practice reached 74.5% while Newtons Practice recorded 67.2%. PCN breast screening is 69.0%, below Mid Sussex (72.5%). Primary care screening shortfalls could delay early tumour detection.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
Cancer waits and diagnostics reflect wider provider performance, not PCN delivery. In provisional July 2026 data, University Hospitals Sussex NHS Foundation Trust achieved 65.2% against the 85.0% 62-day standard, trailing Surrey and Sussex Healthcare NHS Trust (70.0%), NHS Surrey and Sussex Integrated Care Board (71.5%) and England (71.2%), while Maidstone and Tunbridge Wells NHS Trust achieved 87.4%. The trust achieved 74.0% on the 28-day faster diagnosis standard (England 79.3%). For diagnostics in July 2026, 39.3% waited 6+ weeks for colonoscopy and 45.4% for flexi sigmoidoscopy (Surrey and Sussex Healthcare NHS Trust 15.1% and 14.4%).
| Pathways within standard (%) | Sussex | Surrey and Sussex Healthcare | Maidstone and Tunbridge Wells | Surrey and Sussex ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 74.01 | 77.74 | 81.78 | 79.29 | 79.32 |
| 31-day treatment (96%) | 76.79 | 96.20 | 98.35 | 90.45 | 92.50 |
| 62-day referral to treatment (85%) | 65.20 | 69.97 | 87.43 | 71.51 | 71.16 |
| Diagnostic waits over 6 weeks (%) | Sussex | Surrey and Sussex Healthcare | Maidstone and Tunbridge Wells | England |
|---|---|---|---|---|
| MRI | 5.62 | 27.53 | 0.92 | 21.40 |
| CT | 8.57 | 18.49 | 0.51 | 9.92 |
| Echocardiography | 0.39 | 43.78 | 2.57 | 28.48 |
| Colonoscopy | 39.35 | 15.11 | 19.80 | 30.83 |
| Gastroscopy | 20.02 | 21.06 | 24.03 | 29.02 |
| All 15 DM01 tests | 12.95 | 28.50 | 6.42 | 23.14 |
| Community services activity | West Sussex residents | Surrey and Sussex ICB |
|---|---|---|
| Care contacts | 78,050 | 309,615 |
| Referrals | 16,015 | 66,930 |
| Patients with a contact | 19,770 | 85,660 |
Community services (residents of West Sussex), Jun 2026 (provisional). Community activity reflects local authority and system volumes, not PCN patients. In provisional June 2026 data, West Sussex residents had 78,050 community care contacts across 19,770 patients, while NHS Surrey and Sussex Integrated Care Board recorded 309,615 contacts across 85,660 patients. Adults aged 65+ accounted for 72.7% of West Sussex contacts (56,740 contacts), consistent with substantial older-age community activity.
Practice variation and patient experience
Phone access spans 35.1 percentage points between practices alongside divergent vaccination achievement
In 2025/26, overall QOF achievement was 91.3% at Dolphins Practice and 97.0% at Newtons Practice against England's 92.5%. Vaccination and immunisation achievement showed a 13.8 pp spread, from 59.7% at Dolphins Practice to 73.5% at Newtons Practice (England 55.2%). QOF points reflect incentivised delivery rather than population-wide coverage.
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Newtons Practice | 125 | 0.0 | 84.5% | 61.4% | 91.7% |
| Dolphins Practice | 108 | 0.0 | 49.4% | 76.4% | 77.1% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Fourteen of 25 tracked three-year measures trail England, led by declining dementia registers
Fourteen of 25 tracked three-year change measures trail England over 2023 to 2025. Dementia QOF prevalence fell 2.9% (England +6.0%), hypertension prevalence rose +2.7% (England +5.6%), and statin therapy in diabetes without CVD fell 0.01% (England +2.1%). In contrast, clinical reviews expanded rapidly: heart failure reviews rose +56.1% (England +8.7%), asthma reviews grew +18.5% (England +4.4%), and breast screening coverage increased +16.1% over 2023 to 2024 (England +8.4%). These diverging trajectories suggest strong gains in routine reviews alongside slower expansion of chronic disease registers.
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
Dementia register
Hypertension register
Cancer register
Diabetes statin (no CVD)
Stroke register
Heart failure reviews
Asthma reviews
Breast screening (53-70)
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Mid Sussex | Asset | PCN | Mid Sussex |
|---|---|---|---|---|---|
| Care homes (catchment) | 20 (912 beds) | n/a | Schools (catchment) | 48 | n/a |
| Children's centres | 2 | 8 | Places of worship | 34 | 95 |
| Libraries | 1 | 4 | Homelessness support (VCS) | 0 | no data |
| Day centres (VCS) | n/a | 2 | Carers support groups (VCS) | n/a | 1 |
| Primary schools (LA maintained) | 3 | 19 | Primary academies | 10 | 22 |
| Special schools | n/a | 1 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Hypertension case-finding and coding review
Recorded QOF hypertension prevalence is 14.1% (3,531 patients), below England (15.2%) and Mid Sussex (16.1%), yielding an unadjusted gap range of +340 to +554 patients across the 25,420 list. Low cost, quick to run.
Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.
Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).
Option 2
SMI physical health check outreach
Across 247 SMI register patients, annual checks trail Mid Sussex and England for BP (75.5% vs 84.7% and 83.4%), BMI (74.5% vs 84.8% and 82.1%) and alcohol (67.7% vs 82.1% and 81.8%). Moderate effort to run.
Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.
Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.
Option 3
Practice telephone and triage review
In the Jan-Apr 2026 GP Patient Survey, ease of phone contact spanned 35.1 pp, from 49.4% at Dolphins Practice to 84.5% at Newtons Practice (England 56.9%). For discussion: the PCN could audit peak call demand, queue drop-offs and reception triage workflows at Dolphins Practice, comparing routing arrangements with Newtons Practice. Low cost, quick to run.
Evidence base: patient-reported access and experience is the demand-side signal on primary-care capacity and access model; practices with sustained poor experience are the ones to prioritise for access-model support.
Policy anchor: 10 Year Health Plan, shift from hospital to community (Neighbourhood Health Service).
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Older adult anticipatory care (p2) | Aged 65+ | Neighbourhood health framework · NHS vaccination strategy | PCN |
| SMI physical health checks (p4) | SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN |
| Hypertension case finding review (p5) | Hypertension: QOF prevalence | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Childhood immunisation recall pathway (p6) | MMR dose 1 coverage at 24 months | 10YHP sickness to prevention · 95% target | PCN |
| Cervical screening uptake campaign (p7) | Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) | Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026 | PCN |
| Review telephony and triage pathways (p9) | GPPS easy to contact the practice by phone | 10YHP, hospital to community | Practice |
| Option 1 · Hypertension case-finding and coding review (p12) | Hypertension register · Hypertension: QOF prevalence · Registered population | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Option 2 · SMI physical health check outreach (p12) | Severe mental illness register · SMI register with a BP check in the last 12 months · Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs) | MHIS · From Harm to Hope | PCN |
| Option 3 · Practice telephone and triage review (p12) | GPPS easy to contact the practice by phone · GPPS good overall experience of the practice · GPPS survey response rate | 10YHP, hospital to community | Practice |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | ICB | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
